The burden of prostate cancer in Asian nations

Journal of Carcinogenesis

Volumn 11, Issue , 2012, Pages

  Cullen, Jennifer ^a,b,c   Elsamanoudi, Sally ^a,b,c   Brassell, Stephen ^a,b,c   Chen, Yongmei ^a,b,c   Colombo, Monica ^c   Srivastava, Amita ^a   McLeod, David ^a,b,c  

^a Center for Prostate Disease Research   (United States)

^b Henry M Jackson Foundation for the Advancement of Military Medicine   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

Age standardized incidence rate; Asia; cancer incidence in five continents; GLOBOCAN; prostate cancer

Indexed keywords

ARTICLE; ASIAN; CANCER EPIDEMIOLOGY; CHINA; HONG KONG; HUMAN; INDIA; JAPAN; KOREA; MALE; PROSTATE CANCER; SINGAPORE;

EID: 84872772846     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.94025     Document Type: Article

References (34)

1. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer Incidence in Five Continents: Vol. 9. IARC Scientific Publications No. 160. Lyon, France: International Agency for Research on Cancer; 2007.
2. Doll R, Muir CS, Waterhouse JA. Cancer Incidence in Five Continents, Vol. II. Union Internationale Contre le Cancer, Geneva. 1970.
3. Doll R, Payne P, Waterhouse JA. Cancer Incidence in Five Continents, Vol. 1. Geneva; Union Internationale Contre le Cancer; 1966.
4. Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents, Vol. 1-9. IARC Cancer Base No. 9. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://ci0 5.iarc.fr. [Last accessed on 2011 Dec 13].
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Vo1. 2. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr. [Last accessed on 2011 Jan 11].
6. Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL. Cancer Incidence in Five Continents, Vol. 5. Lyon: IARC Scientific Publications No. 88, IARC; 1987.
7. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. 6. Lyon: IARC Scientific Publications No. 120, IARC; 1992.
8. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents, Vol. 7. Lyon: IARC Scientific Publications No. 143, IARC; 1997.
9. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Vol. 8; Lyon: IARC Scientific Publications No. 155, IARC; 2002.
10. Waterhouse J, Muir CS, Correa P, Powell J. Cancer Incidence in Five Continents, Vol. 3. Lyon: IARC Scientific Publications No. 15, IARC; 1976.
11. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J. Cancer Incidence in Five Continents, Vol. 4. Lyon: IARC Scientific Publications No. 42, IARC; 1982.
12. Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, et al. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer 2010;127:2918-27.
13. UN UN. Department of Economic and Social Affairs, Population Division, 2009. World Population Prospects: The 2008 Revision, Highlights, Working Paper No. ESA/P/WP.210. New York: 2008.
14. Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-57). Department of Public Health. Sendai, Japan: Tohoku University of Medicine; 1960.
15. Doll R, Payne P, Waterhouse JA. Cancer Incidence in Five Continents. Vol. 1. Geneva: The international union against cancer; 1966.
16. Akaza H. Aim of the working group on the Asian perspectives on cancer control: Asian perspective on prostate cancer prevention. Jpn J Clin Oncol 2010;40 Suppl 1:i2-6.
17. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009;53:171-84.
18. Pu YS, Chiang HS, Lin CC, Huang CY, Huang KH, Chen J. Changing trends of prostate cancer in Asia. Aging Male 2004;7:120-32. (Pubitemid 39272935)
19. Zhang L, Yang BX, Zhang HT, Wang JG, Wang HL, Zhao XJ. Prostate cancer: an emerging threat to the health of aging men in Asia. Asian J Androl 2011;13:574-8.
20. Delongchamps NB, Singh A, Haas GP. The role of prevalence in the diagnosis of prostate cancer. Cancer Control 2006;13:158-68. (Pubitemid 44469736)
21. Namiki M, Akaza H, Lee SE, Song JM, Umbas R, Zhou L, et al. Prostate Cancer Working Group report. Jpn J Clin Oncol 2010;40 Suppl 1:i70-5.
22. Zhang L, Wu S, Guo LR, Zhao XJ. Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China. Asian J Androl 2009;11:9-13.
23. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010;25:1113-21.
24. Fukagai T, Shimada M, Yoshida H, Namiki T, Carlile RG. Clinical-pathological comparison of clinical prostate cancer between Japanese Americans in Hawaii and Japanese living in Japan. Int J Androl 2000;23 Suppl 2:43-4. (Pubitemid 30330233)
25. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 2008;15:3866-71.
26. Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer-part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 1999;91:1033-9. (Pubitemid 29293042)
27. Feuer EJ, Mariotto A, Merrill R. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates. Cancer 2002;95:870-80.
28. Neppl-Huber C, Zappa M, Coebergh JW, Rapiti E, Rachtan J, Holleczek B, et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol 2011. [In Press].
29. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.
30. Peyromaure EM, Mao K, Sun Y, Xia S, Jiang N, Zhang S, et al. A comparative study of prostate cancer detection and management in China and in France. Can J Urol 2009;16:4472-7.
31. Peyromaure M, Debr B, Mao K, Zhang G, Wang Y, Sun Z, et al. Management of prostate cancer in China: a multicenter report of 6 institutions. J Urol 2005;174:1794-7. (Pubitemid 41546942)
32. Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Araya M, et al. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey. Int J Radiat Oncol Biol Phys 2011;81:1310-8.
33. Na YQ. Are we ready for prostate cancer? Chin Med J (Engl) 2008;121:291.
34. Ahmad OB, Bosci-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age Standardization of Rates: a new WHO Standard. In GPE Discussion Paper Series: No. 31. Geneva: World Health Organization; 2000.